Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: A single-institution study

Antonio Silvani, Marica Eoli, Andrea Salmaggi, Elena Lamperti, Laura Fariselli, Ida Milanesi, Giovanni Broggi, Carlo Lazzaro Solero, Sergio Giombini, Amerigo Boiardi

Research output: Contribution to journalArticlepeer-review

Abstract

We report on our experience in the treatment of intracranial germinomas (18 pure germinomas and two germinomas with syncytiotrophoblastic giant cells) according to a strategy of radiotherapy doses and fields reduction after a neoadjuvant chemotherapy (Cisplatin-vinblastine and bleomycin combination). Radiation therapy was delivered after the completion of the third and last course of chemotherapy. For the solitary germinoma the target volume was the gross tumour volume. In the five multifocal germinoma patients the whole ventricle volume was irradiated. For the single disseminated germinoma patient we treated the whole central nervous system. The cumulative doses were 30 Gy for the pure germinomas. For the STGCs, a cumulative dose of 35 Gy was used. The median follow-up was 55 months (range 12-120). 18 patients were alive without recurrence of disease. In the two patients with STGCs the death took place 16 and 35 months after diagnosis.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalJournal of Neuro-Oncology
Volume71
Issue number3
DOIs
Publication statusPublished - Feb 2005

Keywords

  • Bleomycin
  • Chemotherapy
  • Cisplatinum
  • Germinomas
  • Radiotherapy
  • Vinblastine

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: A single-institution study'. Together they form a unique fingerprint.

Cite this